Current Opinion in Oncology

Papers
(The H4-Index of Current Opinion in Oncology is 15. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Neoadjuvant immunotherapy in melanoma: pathological response as a surrogate endpoint?50
Is there still a place for lymph node dissection for stage III melanoma since the approval of adjuvant therapy38
The role of signaling lymphocyte activation molecule family receptors in hematologic malignancies30
Harnessing dendritic cells for innovative therapeutic cancer vaccines26
Progress in diagnosis and treatment of checkpoint inhibitor pneumonitis24
Content features and its implementation in novel app-based psycho-oncological interventions for cancer survivors: a narrative review24
Role of PSMA PET/CT in imaging and management of prostate cancer21
Neurorehabilitation in brain tumours: evidences and suggestions for spreading of knowledge and research implementation21
Collecting information from all sarcoma reference cancer centres worldwide: achievement and next steps20
Editorial introductions18
Treatments and challenges in advanced prostate cancer18
State of the art and upcoming trends in HER2-directed therapies in gastrointestinal malignancies18
First and further-line multidisciplinary treatment of retroperitoneal sarcomas17
Psycho-oncology interventions focusing on fatigue and sleep disturbances16
Editorial introductions15
Epigenetic dynamics of aging and cancer development: current concepts from studies mapping aging and cancer epigenomes15
0.096748113632202